ArticleBiological psychiatry. Cognitive neuroscience and neuroimaging2026
Brainwide Structural Markers of Familial and Clinical Risk for Bipolar Disorder in Youth.
Article in Biological psychiatry. Cognitive neuroscience and neuroimaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundBipolar disorder (BD) is a severe mental illness, often emerging during adolescence, that is associated with significant psychosocial impairment. BD risk is elevated in offspring of affected parents, particularly those with antecedent symptoms (e.g., mood lability, subthreshold manic symptoms). However, robust, replicable brain-based markers of risk in this population are lacking. We assessed the degree to which the regional vulnerability index for BD (RVI-BD), quantified as an individual's brainwide similarity to BD patterns derived from meta-analytic studies, is elevated in youth at familial risk and correlates with symptom predictors of BD.
methodsWe recruited 82 adolescents (ages 10-15 years), 41 with a first-degree relative with BD (at-risk) and 41 healthy control (HC) participants. The RVI-BD was calculated separately based on cortical thickness (CT) and subcortical volume (SV) patterns, by computing the average of RVI-BD metrics derived using case-control (alignment with BD patterns) and dimensional (alignment and deviation toward BD patterns) approaches.
resultsCompared with HC participants, at-risk youth showed higher CT-RVI-BD (d = 0.66, p = .006). Group differences were driven largely by at-risk individuals with attention-deficit/hyperactivity disorder (ADHD); however, ADHD was not associated with the RVI-BD in a separate population-based sample, suggesting that the combination of familial risk and ADHD most strongly predicts CT-RVI-BD. CT-RVI-BD (and to a lesser degree SV-RVI-BD) were also associated with parent-reported symptom scales, including subthreshold manic symptoms and mood lability.
conclusionsFindings suggest the RVI-BD as a potential marker of familial and clinical risk for BD. Future work should assess the degree to which CT-RVI-BD predicts longitudinal mood trajectories in at-risk youth.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.